Leads Biolabs is developing LBL-047, a new bispecific antibody for autoimmune diseases that targets B cells and pDCs. LBL-047 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results